JP2023534206A5 - - Google Patents
Info
- Publication number
- JP2023534206A5 JP2023534206A5 JP2023501477A JP2023501477A JP2023534206A5 JP 2023534206 A5 JP2023534206 A5 JP 2023534206A5 JP 2023501477 A JP2023501477 A JP 2023501477A JP 2023501477 A JP2023501477 A JP 2023501477A JP 2023534206 A5 JP2023534206 A5 JP 2023534206A5
- Authority
- JP
- Japan
- Prior art keywords
- mol
- lipid
- formulation according
- nucleic acid
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063050594P | 2020-07-10 | 2020-07-10 | |
| US63/050,594 | 2020-07-10 | ||
| PCT/US2021/040913 WO2022011156A1 (en) | 2020-07-10 | 2021-07-08 | Lipid nanoparticles for delivering therapeutics to lungs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023534206A JP2023534206A (ja) | 2023-08-08 |
| JP2023534206A5 true JP2023534206A5 (https=) | 2024-07-03 |
Family
ID=79552114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501477A Pending JP2023534206A (ja) | 2020-07-10 | 2021-07-08 | 肺に治療薬を送達するための脂質ナノ粒子 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240065982A1 (https=) |
| EP (1) | EP4178585A4 (https=) |
| JP (1) | JP2023534206A (https=) |
| KR (1) | KR20230038217A (https=) |
| CN (1) | CN115768438A (https=) |
| AU (1) | AU2021305214A1 (https=) |
| CA (1) | CA3188661A1 (https=) |
| IL (1) | IL299750A (https=) |
| MX (1) | MX2023000511A (https=) |
| WO (1) | WO2022011156A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019376006A1 (en) | 2018-11-09 | 2021-06-03 | Arbutus Biopharma Corporation | Cationic lipids containing silicon |
| CZ310613B6 (cs) | 2020-09-23 | 2026-01-28 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| CZ310443B6 (cs) | 2021-07-19 | 2025-06-25 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití |
| WO2023184038A1 (en) | 2022-04-01 | 2023-10-05 | Nanovation Therapeutics Inc. | Mrna delivery method and composition thereof |
| JP2025535237A (ja) * | 2022-10-25 | 2025-10-24 | ナノベーション・セラピューティクス・インコーポレイテッド | アンチセンスオリゴヌクレオチド送達のための脂質ナノ粒子製剤 |
| WO2025133951A1 (en) * | 2023-12-21 | 2025-06-26 | Genevant Sciences Gmbh | Ionizable lipids suitable for lipid nanoparticles |
| WO2025166325A1 (en) | 2024-02-02 | 2025-08-07 | Editas Medicine, Inc. | MODIFIED GUIDE RNAs |
| WO2025213138A1 (en) | 2024-04-05 | 2025-10-09 | Editas Medicine, Inc. | Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma |
| CN118576568B (zh) * | 2024-08-06 | 2024-11-26 | 北京悦康科创医药科技股份有限公司 | 一种药物组合物及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2721333C (en) * | 2008-04-15 | 2020-12-01 | Protiva Biotherapeutics, Inc. | Novel lipid formulations for nucleic acid delivery |
| US20180200186A1 (en) * | 2015-07-09 | 2018-07-19 | Insmed Incorporated | Compositions and methods for treating lung diseases and lung injury |
| CA3103528A1 (en) * | 2018-06-19 | 2019-12-26 | The Board Of Regents Of The University Of Texas System | Lipid nanoparticle compositions for delivery of mrna and long nucleic acids |
| DE102018127300A1 (de) * | 2018-10-31 | 2020-04-30 | Henkel Ag & Co. Kgaa | Wirkstoffzusammensetzung zum Schutz künstlich gefärbter Haare |
| AU2019376006A1 (en) * | 2018-11-09 | 2021-06-03 | Arbutus Biopharma Corporation | Cationic lipids containing silicon |
| EP3959314A4 (en) * | 2019-04-26 | 2023-02-08 | Genevant Sciences Gmbh | LIPIDNANOPARTICLES |
-
2021
- 2021-07-08 WO PCT/US2021/040913 patent/WO2022011156A1/en not_active Ceased
- 2021-07-08 MX MX2023000511A patent/MX2023000511A/es unknown
- 2021-07-08 EP EP21836897.5A patent/EP4178585A4/en active Pending
- 2021-07-08 CA CA3188661A patent/CA3188661A1/en active Pending
- 2021-07-08 AU AU2021305214A patent/AU2021305214A1/en active Pending
- 2021-07-08 US US18/015,398 patent/US20240065982A1/en active Pending
- 2021-07-08 KR KR1020237003860A patent/KR20230038217A/ko active Pending
- 2021-07-08 CN CN202180048101.4A patent/CN115768438A/zh active Pending
- 2021-07-08 JP JP2023501477A patent/JP2023534206A/ja active Pending
- 2021-07-08 IL IL299750A patent/IL299750A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023534206A5 (https=) | ||
| EP2567693B1 (en) | Lipid encapsulated interfering RNA | |
| US9080186B2 (en) | Compositions comprising cationic amphiphiles and colipids for delivering therapeutic molecules | |
| US9074208B2 (en) | Modified siRNA molecules and uses thereof | |
| US9181295B2 (en) | Cationic lipids with various head groups for oligonucleotide delivery | |
| US7838658B2 (en) | siRNA silencing of filovirus gene expression | |
| US20070218122A1 (en) | siRNA silencing of influenza virus gene expression | |
| JP2022501064A5 (https=) | ||
| TW202539707A (zh) | 用於治療ｂ型肝炎之治療組成物及方法 | |
| US20240050463A1 (en) | Therapeutic compositions and methods for treating hepatitis b | |
| JP2023518944A5 (https=) | ||
| HK40115528A (zh) | 含有苯环结构的长效脾靶向阳离子脂质化合物、包含其的组合物及用途 | |
| HK40115528B (zh) | 含有苯环结构的长效脾靶向阳离子脂质化合物、包含其的组合物及用途 | |
| HK1123751B (en) | Lipid encapsulated interfering rna |